Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : Merck Sharp and Dohme de España

Femme et Homme Max 99 ans
Merck Sharp and Dohme de España MAJ Il y a 4 ans

A prospective, multicenter, randomized, double-blind, pilot study to evaluate the safety, the efficacy, the tolerability, and the emergence of resistant gram-negative microorganisms in the bowel in elderly patients with serious community-acquired bacterial pneumonia treated with a short regimen fo ertapenem versus high-dose levofloxacin a. In elderly patients (≥ 65 years old) who are clinically evaluable, to assess the efficacy of ertapenem with respect to high-dose levofloxacin measured as the proportion of patients achieving a favo...

Pays Aucun
Organes Aucun
Spécialités Aucune

unknown

Plus d'informations